Biography
2024: TAdviser interview
Artificial intelligence is increasingly finding its way into new fields. However, the development and implementation of such solutions in medicine should be carried out with maximum caution in order to prevent possible harm to patients. Today we have the opportunity to talk with the head of the startup PathVision.ai, who not only made a breakthrough in the field of medical diagnostics, but was the first on the Russian market to receive a registration certificate from Roszdravnadzor for pathomorphology based on artificial intelligence. This startup applies Deep Learning technology to detect prostate cancer, allowing doctors to make diagnoses faster and more accurately. The founder of the company, Gennady Popov, told TAdviser how a small team of enthusiasts managed to achieve such heights, what challenges they overcame and what plans they are making for the future. Read more here.
Photos of the Gennady Viktorovich Popov
| The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |